<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-5N3XO8QN</identifier><date>2006</date><creator>Geis, Nicolas</creator><creator>Kirschfink, Michael</creator><creator>Konatschnig, Thomas</creator><creator>Schultz, Stefan</creator><relation>documents/znanstveni_clanki/radiology_and_oncology/html/urn_nbn_si_doc-5n3xo8qn.html</relation><relation>documents/znanstveni_clanki/radiology_and_oncology/pdf/urn_nbn_si_doc-5n3xo8qn.pdf</relation><relation>documents/znanstveni_clanki/radiology_and_oncology/txt/urn_nbn_si_doc-5n3xo8qn.txt</relation><format format_type="main">12 strani</format><format format_type="issue">2</format><format format_type="volume">40</format><format format_type="type">article</format><format format_type="extent">str. 95-105</format><identifier identifier_type="ISSN">1318-2099</identifier><identifier identifier_type="COBISSID">21604057</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-5N3XO8QN</identifier><language>eng</language><publisher>Association of Radiology and Oncology</publisher><source>Radiology and oncology (Ljubljana)</source><rights>BY</rights><subject language_type_id="eng">Antibodies, Monoclonal</subject><subject language_type_id="slv">antigeni</subject><subject language_type_id="slv">Antigeni, CD59</subject><subject language_type_id="eng">Antigens, Cd59</subject><subject language_type_id="eng">Complement Inactivators</subject><subject language_type_id="eng">Drug Therapy</subject><subject language_type_id="eng">Immunology</subject><subject language_type_id="eng">Immunotherapy</subject><subject language_type_id="slv">Imunoterapija</subject><subject language_type_id="slv">Komplement, inaktivatorji</subject><subject language_type_id="eng">Neoplasms</subject><subject language_type_id="slv">Novotvorbe</subject><subject language_type_id="slv">odpornost</subject><subject language_type_id="slv">onkologija</subject><subject language_type_id="slv">Protitelesa monoklonska</subject><subject language_type_id="eng">tumor</subject><subject language_type_id="slv">tumorske celice</subject><title>Complement resistance impairs anti-tumour therapy</title></Record>